Methamphetamine-induced serotonin neurotoxicity is attenuated in p53- knockout mice

Brain Research

Volumn 768, Issue 1-2, 1997, Pages 345-348

  Hirata, Hiroshi ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Knockout mouse; Methamphetamine; Neurotoxicity; P53; Serotonin transporter

Indexed keywords

METHAMPHETAMINE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; CELL DAMAGE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG RECEPTOR BINDING; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEROTONIN RELEASE; TRANSPORT KINETICS; TUMOR SUPPRESSOR GENE;

ANALYSIS OF VARIANCE; ANIMALS; GENES, P53; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; NEUROTOXINS; SEROTONIN AGENTS;

EID: 0030765965     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00798-1     Document Type: Article

References (22)

1. Bakhit C., Morgan M.E., Peat M.A., Gibb J.W. Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology. 20:1981;1135-1140.
2. J.L. Cadet, C. Brannock, Invited review: Free radicals and the pathobiology of brain dopamine systems, Neurochem. Int. (1997) in press.
3. Cadet J.L., Sheng P., Ali S., Rothman R., Carlson E., Epstein C.J. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:1994;380-383.
4. J.F. Cubells, S. Rayport, G. Rayndrion, D. Sulzer, Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress, J. Neurosci. 14 (1994) 2260-2271.
5. De Vito M.J., Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1989;1145-1150.
6. Donehower L.A., Harvey M., Siagel B.L., McArthur M.J., Montogomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
7. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene. 8:1993;307-318.
8. H. Hirata, J.L. Cadet, p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies, J. Neurochem. (1997) in press.
9. Hirata H., Ladenheim B., Rothman R.B., Epstein C., Cadet J.L. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
10. Hirata H., Ladenheim B., Carlson E., Epstein C., Cadet J.L. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714:1996;95-103.
11. Johnson M., Stone D., Hanson G.R., Gibb J.W. Role of the dopaminergic neuronal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur. J. Pharmacol. 135:1987;231-234.
12. Kastan M.B., Onyewere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
13. 3H]cyanoimipramine autoradiography. Brain Res. 505:1989;123-129.
14. Lowe S.W., Ruley H.E., Jacks T., Housman O.E. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;1957-1967.
15. Morgenbesser S.D., Williams B.O., Jacks T., Depinho R.A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 371:1994;72-74.
16. Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: regional study. Brain Res. 193:1980;153-163.
17. Schmidit C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240:1987;1-7.
18. Seiden L.S., Commins D.L., Vosmer G., Axt K., Marek G. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections. Ann. NY Acad. Sci. 537:1988;161-172.
19. Wagner A.J., Kokontis J.M., Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip1. Genes Dev. 8:1994;2817-2830.
20. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induced apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
21. Zaczek R.A., Battaglia G., Contrera J.F., Culp S., De Souza E.B. Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamine. Toxicol. Appl. Pharmacol. 100:1989;227-233.
22. Zhan Q., Carrier F., Fornace A.J. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell. Biol. 13:1993;4242-4250.